Hostname: page-component-5c6d5d7d68-wp2c8 Total loading time: 0 Render date: 2024-08-13T16:08:19.602Z Has data issue: false hasContentIssue false
  • English
  • Français

A Comparison of the Effects of Varying Dose Levels of Oxypertine on Mood and Physical Performance of Trained Athletes

Published online by Cambridge University Press:  29 January 2018

G. T. Adamson  and
S. E. Finlay
G. T. Adamson
Affiliation:
Department of Physical Education
S. E. Finlay
Affiliation:
University of Leeds, Leeds, 2
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Oxypertine (also known as Win. 18,501–2) is a member of a series of alkyl indolyl-4-phenyl piperazines (Archer et al., 1962), and is 1-[2-(5,6 -Dimethoxy-2-methyl-3-indolyl) ethyl]-4-phenylpiperazine.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 112 , Issue 492 , November 1966 , pp. 1177 - 1180
Copyright
Copyright © Royal College of Psychiatrists, 1966 

References

Adamson, G. T., and Finlay, S. E. (1965). “The effects of two psycho-stimulant drugs on muscular performance in male athletes.” Ergonomics, 8, 237–241.CrossRefGoogle Scholar
Archer, S. et al. (1962). “1-(indolylalkyl)-4-aryl-piperazines: a new class of tranquillizers.” J. Amer. chem. Soc., 84, 1306.CrossRefGoogle Scholar
Cole, J. O., and Edwards, R. E. (1964). “Prediction of clinical effects of psychotropic drugs from animal data.” Ciba Foundation Symposium: Animal Behaviour and Drug Action, 286–298, London: Churchill.Google Scholar
Durell, J., and Pollin, W. (1963). “A trial on chronic schizophrenic patients of oxypertine, a psychotropic drug with an indole ring.” Brit. J. Psychiat., 109, 687–691.Google Scholar
Flament, J., Lofft, J. G., and von Mendelssohn, F. (1964). “Clinical investigation of psychopharmacological effects of Win. 18,501–2.” Neuro-Psychopharmacology Proceedings: 3rd International Congress of Collegium Internationale Neuro-Psychopharmacologium, Munich, 1962, 3, 275. Amsterdam: Elsevier.Google Scholar
Friedhoff, A. J., and Hekimian, L. (1963). “A pilot study of Win. 18,501.” Dis. nerv. Syst., 24, 241–242.Google Scholar
Hollister, L. E., Overall, J. E., Kimball, T., Bennet, J. L., Meyer, F., and Caffey, E. (1963). “Oxypertine in newly admitted schizophrenics.” J. new Drugs, 3, 26–31.CrossRefGoogle ScholarPubMed
Lasagna, L., von Felsinger, J. M., and Beecher, H. K. (1955). “Drug-induced mood changes in man.” J. Amer. med. Ass., 157, 1006–1020.Google Scholar
Randrup, A., and Munkvad, I. (1964). “On the relation of tryptaminic and serotenergic mechanisms to amphetamine-induced abnormal behaviour.” Acta Pharmacol. et toxicol., 21, 272–282.Google Scholar
Smith, G. M., and Beecher, H. K. (1960). “Amphetamine, secobarbital and athletic performance.” J. Amer. med. Ass., 172, 1052–1514.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.